These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30312670)

  • 41. Additional elastography-targeted biopsy improves the agreement between biopsy Gleason grade and Gleason grade at radical prostatectomy.
    Boehm K; Tennstedt P; Beyer B; Schiffmann J; Beckmann A; Michl U; Beyersdorff D; Budäus L; Graefen M; Karakiewicz PI; Salomon G
    World J Urol; 2016 Jun; 34(6):805-10. PubMed ID: 26481227
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.
    van Poppel H; Haese A; Graefen M; de la Taille A; Irani J; de Reijke T; Remzi M; Marberger M
    BJU Int; 2012 Feb; 109(3):360-6. PubMed ID: 21883822
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
    De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
    AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy.
    Guttilla A; Zazzara M; Zattoni F; Novara G; Zanin M; Gardiman M; Ficarra V; Zattoni F
    BJU Int; 2015 Aug; 116(2):202-6. PubMed ID: 24750975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of prostate cancer with dynamic contrast-enhanced computed tomography using an en bloc approach.
    Huellner MW; Pauli C; Mattei A; Ross S; Diebold J; Vosbeck J; Allgayer B; Strobel K; Veit-Haibach P
    Invest Radiol; 2014 Sep; 49(9):571-8. PubMed ID: 24710202
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer.
    Albitar M; Ma W; Lund L; Shahbaba B; Uchio E; Feddersen S; Moylan D; Wojno K; Shore N
    Prostate; 2018 Mar; 78(4):294-299. PubMed ID: 29315679
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blinded review of archival radical prostatectomy specimens supports that contemporary Gleason score 6 prostate cancer lacks metastatic potential.
    Nunez Bragayrac LA; Murekeyisoni C; Vacchio MJ; Attwood K; Mehedint DC; Mohler JL; Azabdaftari G; Xu B; Kauffman EC
    Prostate; 2017 Jul; 77(10):1076-1081. PubMed ID: 28547760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of two gene panels for prostate cancer diagnosis and patient risk stratification.
    Xiao K; Guo J; Zhang X; Feng X; Zhang H; Cheng Z; Johnson H; Persson JL; Chen L
    Tumour Biol; 2016 Aug; 37(8):10115-22. PubMed ID: 26820133
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.
    Cole AI; Morgan TM; Spratt DE; Palapattu GS; He C; Tomlins SA; Weizer AZ; Feng FY; Wu A; Siddiqui J; Chinnaiyan AM; Montgomery JS; Kunju LP; Miller DC; Hollenbeck BK; Wei JT; Mehra R
    J Urol; 2016 Aug; 196(2):405-11. PubMed ID: 26920466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
    Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
    J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prostate cancer grading: the effect of stratification of needle biopsy Gleason Score 4 + 3 as high or intermediate grade.
    Fanning DM; Kay E; Fan Y; Fitzpatrick JM; Watson RW
    BJU Int; 2010 Mar; 105(5):631-5. PubMed ID: 19732053
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Definitive pathology at radical prostatectomy is commonly favorable in men following initial active surveillance.
    Hong SK; Sternberg IA; Keren Paz GE; Kim PH; Touijer KA; Scardino PT; Eastham JA
    Eur Urol; 2014 Aug; 66(2):214-9. PubMed ID: 23954083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer: therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores.
    Kupelian P; Katcher J; Levin H; Zippe C; Suh J; Macklis R; Klein E
    Cancer J Sci Am; 1997; 3(2):78-87. PubMed ID: 9099457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gleason score and tumor laterality in radical prostatectomy and transrectal ultrasound-guided biopsy of the prostate: a comparative study.
    Pereira RA; Costa RS; Muglia VF; Silva FF; Lajes JS; Dos Reis RB; Silva GE
    Asian J Androl; 2015; 17(5):815-20. PubMed ID: 25652629
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic accuracy of Prostate Health Index and urinary Prostate Cancer Antigen 3 in predicting pathologic features after radical prostatectomy.
    Cantiello F; Russo GI; Ferro M; Cicione A; Cimino S; Favilla V; Perdonà S; Bottero D; Terracciano D; De Cobelli O; Morgia G; Damiano R
    Urol Oncol; 2015 Apr; 33(4):163.e15-23. PubMed ID: 25575715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Agreement of Gleason score on prostate biopsy and radical prostatectomy specimen: is there improvement with increased number of biopsy cylinders and the 2005 revised Gleason scoring?
    Van Praet C; Libbrecht L; D'Hondt F; Decaestecker K; Fonteyne V; Verschuere S; Rottey S; Praet M; De Visschere P; Lumen N;
    Clin Genitourin Cancer; 2014 Jun; 12(3):160-6. PubMed ID: 24361055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer.
    Connell SP; O'Reilly E; Tuzova A; Webb M; Hurst R; Mills R; Zhao F; Bapat B; Cooper CS; Perry AS; Clark J; Brewer DS
    Prostate; 2020 May; 80(7):547-558. PubMed ID: 32153047
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Gleason scores from sextant prostate biopsies and radical prostatectomy specimens.
    Altay B; Kefi A; Nazli O; Killi R; Semerci B; Akar I
    Urol Int; 2001; 67(1):14-8. PubMed ID: 11464109
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Limitations in Predicting Organ Confined Prostate Cancer in Patients with Gleason Pattern 4 on Biopsy: Implications for Active Surveillance.
    Perlis N; Sayyid R; Evans A; Van Der Kwast T; Toi A; Finelli A; Kulkarni G; Hamilton R; Zlotta AR; Trachtenberg J; Ghai S; Fleshner NE
    J Urol; 2017 Jan; 197(1):75-83. PubMed ID: 27457260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.